Translate to...

Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status

Pfizer Inc and partner BioNTech SE said on Monday, two of their experimental coronavirus vaccine candidates received "fast track" status from the U.S. Food and Drug Administration, which is designed to speed up the regulatory review process.